February 26, 2026 11:45 AM EST

Our Mission

Helping Life Sciences to develop, manufacture and deliver therapies to their patients to the highest safety standard.

Our Vision

To be the Number 1 data-centric system for managing regulated processes across multiple industries worldwide.

8
of the World's Top 10 Life Sciences Companies Use Kneat

Latest Earnings

Q4 2025 Results

Events

More events are coming soon.
SUSTAINABLE VALIDATION WITH KNEAT GX

Value Creation

By reducing environmental impact and driving efficiency, Kneat positions itself as a trusted partner in compliance, sustainability, and shareholder value creation.

Kneat Gx replaces paper-based validation with a sustainable digital platform, cutting paper use, emissions, water consumption, and waste. In 2024 alone, customers saved over 20,000 trees and avoided significant carbon output, while renewable-powered hosting further reduces the footprint.

Beyond environmental gains, organizations achieve faster cycle times, lower costs, and improved efficiency. This dual impact — sustainability plus performance — positions Kneat as a critical enabler of ESG leadership, risk mitigation, and long-term value creation across regulated industries facing rising climate and compliance pressures.

"For life science to scale and bring to market innovative therapies with confidence, digitization and automation of their quality processes is critical. As most of the world's leading pharmaceutical companies roll out Kneat Gx across their validation processes and sites, they lead the way for rest of the life science industry to follow. And since Kneat Gx could ultimately suit any highly regulated process needing a compliant yet flexible platform, we see potential for sustainable growth that extends well into the future."

- Eddie Ryan, CEO

Awards & Recognition

OTCQX Best 50 ranks the 50 top-performing companies based on total return and growth in average daily dollar volume in 2024. The Deloitte Ireland Technology Fast 50 program ranks the 50 fastest-growing technology companies in Ireland based on their revenue growth over the previous four years.